This article explores the threat of AI-washing in the financial services sector, where firms misrepresent AI capabilities, undermining investor trust and market integrity. It advocates for stronger SEC enforcement to combat misleading AI claims and promote transparency.
The FDA’s recent guidance aims to reduce unnecessary regulatory burdens on low-risk digital health tools while maintaining oversight for medical-grade products. This clarity is particularly important in oncology, where decision support tools can significantly impact clinical decisions and patient care.
The executive order on artificial intelligence emphasizes a coordinated federal approach to AI regulation while confirming that employer liability for AI-assisted employment decisions remains grounded in existing civil rights laws. Employers should assess AI-influenced decisions within traditional discrimination frameworks to ensure compliance and reduce legal risks.
Georgia’s 2026 tech philosophy emphasizes that “AI governance is security,” highlighting the critical intersection of cybersecurity and technology growth. The state plans to leverage AI while ensuring robust security measures, focusing on delivering tangible outcomes for citizens and maintaining their trust.
Chinese AI company DeepSeek plans to launch a chatbot tailored for Italy, aiming to comply with strict regulations amid concerns over AI hallucinations. This follows increased scrutiny from Italy’s AGCM watchdog emphasizing transparency and risk management for generative AI.
Okta executives discussed the convergence in the identity market, emphasizing the importance of governance and privileged access management in today’s cloud-driven environment. They highlighted the growth of their governance offerings and the need for a neutral identity layer to secure AI agents in enterprise deployments.
As AI tools become widespread in employment recruiting, new state regulations begin in 2026, requiring employers to ensure compliance to avoid legal penalties and discrimination claims.
As life sciences companies expand internationally, regulatory readiness becomes a strategic capability essential for global business planning. The upcoming Fireside Chat at the J.P. Morgan Healthcare Conference will explore how companies can navigate complex regulatory frameworks and the impacts of the new BIOSECURE Act on supply chains.
Over 70% of S&P 500 companies disclose AI-related risk factors, highlighting the importance of managing risks in cybersecurity, regulatory compliance, operations, ethics, and more to ensure responsible AI use in business.
In this episode of Regulatory Oversight, host Ashley Taylor discusses the Colorado AI Act with Senator Robert Rodriguez and privacy expert David Stauss. They explore the Act’s origins, goals, and provisions, emphasizing consumer protection and the importance of transparency in high-risk AI systems.